Clinical Trials

Search for actively enrolling clinical trials

AALL1231, A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)

Study ID: STU 102014-066

Summary

See protocol/CiRB application

Participant Eligibility

See protocol

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
Tamra Lynn Slone

Contact:

Princess Iroh

princess.iroh-rodgers@childrens.com

Linked In Email
scroll to top